Karachi, March 12, 2025 – Haleon Pakistan Limited has achieved a significant milestone by successfully dispatching the first consignment of its locally manufactured Centrum to Kenya.
This development marks a new chapter in the company’s expansion efforts, positioning Haleon as a key player in Pakistan’s pharmaceutical export sector.
In an official communication to the Pakistan Stock Exchange (PSX) on Wednesday, Haleon Pakistan expressed pride in this accomplishment, highlighting it as the beginning of an exciting journey that will further strengthen its export operations throughout 2025. The company emphasized that this achievement aligns with its broader vision to expand its footprint beyond Pakistan and enhance its presence in international markets.
Haleon’s successful shipment of Centrum is a testament to the company’s dedication to bolstering Pakistan’s economy by generating export-driven growth. By producing high-quality health supplements at its Jamshoro facility, Haleon is not only meeting domestic demand but also creating new trade opportunities that reinforce Pakistan’s standing in the global healthcare industry.
The company acknowledged the vital role played by the relevant authorities in facilitating this milestone. Haleon extended its sincere gratitude to the Special Investment Facilitation Council (SIFC) for its unwavering support in streamlining the export process. The collaboration with regulatory bodies has been instrumental in ensuring smooth operations, allowing Haleon to take this significant step toward international expansion.
Haleon remains committed to further strengthening Pakistan’s position as a competitive exporter of healthcare products. The launch of ‘Made in Pakistan’ Centrum in Kenya signals the company’s long-term vision to diversify its markets and contribute positively to Pakistan’s export sector. This development also underscores the potential for increased foreign exchange earnings and economic resilience through the expansion of Pakistan’s pharmaceutical and nutraceutical industries.
With this inaugural shipment, Haleon is confident in its ability to continue building strong trade relationships with global partners. As the company accelerates its export strategy, Haleon aims to introduce more ‘Made in Pakistan’ products to international markets, showcasing Pakistan’s growing capability in pharmaceutical and healthcare manufacturing.